avatar image
Advertisement

Global coronavirus vaccination programmes put Chinese syringe makers under tremendous pressure as orders mount

  • Companies like Zhejiang KangKang and Shandong Qiaosen are working round the clock and trying to expand production
  • Prices of syringes have more than tripled from 0.1 yuan (1.55 US cents) each before the outbreak to more than 0.3 yuan now

Reading Time:2 minutes
Why you can trust SCMP
0
A health worker receives a coronavirus vaccine developed by Oxford/AstraZeneca in India last month. Photo: Reuters

Chinese syringe makers are warning that they may only be able to fulfil some orders as late as June, as global coronavirus vaccination programmes put unprecedented levels of pressure on their factory lines and snarl the country’s own vaccine efforts.

Companies said that they were working around the clock, raising prices and trying to expand factory lines. China and India are the world’s biggest producers of syringes, industry executives said.

Zhejiang KangKang Medical Devices began receiving export contracts for 10 million to 20 million syringes each in December, compared with order sizes of about 5 million each before the pandemic, thanks to overseas vaccination programmes, Guo Chun, its general manager, told Reuters.

The company, a unit of Wanbangde Pharmaceutical Holding, was adding capacity to quadruple its production for certain types of syringes by May, but until then can only partly fulfil large orders, he said.

09:50

SCMP Explains: What's the difference between the major Covid-19 vaccines?

SCMP Explains: What's the difference between the major Covid-19 vaccines?

“We are very careful in taking in new orders now,” said an office manager surnamed Yang at another manufacturer, Shandong Qiaosen, a supplier to Becton Dickinson that is based in the northern Chinese city of Shandong. He declined to give his full name.

Advertisement